
The global Head Lice Infestation Treatment market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Head lice are small, wingless, blood-sucking insects that attack the hair. They feed on the blood of your scalp, which causes irritation or sometimes large pimples on the head. The male lice are much larger compared to the female lice. Head lice are transmissible if you get infected with head lice. Head lice are characterized by symptoms such as severe itching, tingling sensation when the hair moves, and sores on the scalp, neck, and shoulders. Head lice infestation is caused by poor personal hygiene. Head lice can be treated with over-the-counter drugs and prescribed drugs. There are many treatment options available to get rid of head lice, but most treatments need to be used twice or more. The second treatment takes place after a week to kill any newly hatched nits.
In North America and Europe, Head Lice Infestation Treatment key players include Stada Arzneimittel, Reckitt Benckier, Oystershell Consumer Health, Prestige Brands, Perrigo, etc. Top five manufacturers hold a share about 60%.
Europe is the larger market, with a share over 55%, followed by North America , which has a share over 40%.
In terms of product, OTC is the largest segment, with a share over 95%. And in terms of application, the largest application is children, followed by adults.
This report is a detailed and comprehensive analysis for global Head Lice Infestation Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Head Lice Infestation Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Head Lice Infestation Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Head Lice Infestation Treatment market size and forecasts, by Type and by End User, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Head Lice Infestation Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Head Lice Infestation Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Head Lice Infestation Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Arbor Pharmaceuticals, Stada Arzneimittel, Prestige Brands, Oystershell Consumer Health, Reckitt Benckier, Perrigo, ParaPRO, TecLabs, Alliance Pharma Inc., Nuvo Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Head Lice Infestation Treatment market is split by Type and by End User. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
OTC
Prescription
麻豆原创 segment by End User
Children
Adults
Major players covered
Arbor Pharmaceuticals
Stada Arzneimittel
Prestige Brands
Oystershell Consumer Health
Reckitt Benckier
Perrigo
ParaPRO
TecLabs
Alliance Pharma Inc.
Nuvo Pharmaceuticals
Medexus Pharmaceuticals
Logic Product Group
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Head Lice Infestation Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Head Lice Infestation Treatment, with price, sales quantity, revenue, and global market share of Head Lice Infestation Treatment from 2020 to 2025.
Chapter 3, the Head Lice Infestation Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Head Lice Infestation Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by End User, with sales market share and growth rate by Type, by End User, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Head Lice Infestation Treatment market forecast, by regions, by Type, and by End User, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Head Lice Infestation Treatment.
Chapter 14 and 15, to describe Head Lice Infestation Treatment sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Head Lice Infestation Treatment Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 OTC
1.3.3 Prescription
1.4 麻豆原创 Analysis by End User
1.4.1 Overview: Global Head Lice Infestation Treatment Consumption Value by End User: 2020 Versus 2024 Versus 2031
1.4.2 Children
1.4.3 Adults
1.5 Global Head Lice Infestation Treatment 麻豆原创 Size & Forecast
1.5.1 Global Head Lice Infestation Treatment Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Head Lice Infestation Treatment Sales Quantity (2020-2031)
1.5.3 Global Head Lice Infestation Treatment Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Arbor Pharmaceuticals
2.1.1 Arbor Pharmaceuticals Details
2.1.2 Arbor Pharmaceuticals Major Business
2.1.3 Arbor Pharmaceuticals Head Lice Infestation Treatment Product and Services
2.1.4 Arbor Pharmaceuticals Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Arbor Pharmaceuticals Recent Developments/Updates
2.2 Stada Arzneimittel
2.2.1 Stada Arzneimittel Details
2.2.2 Stada Arzneimittel Major Business
2.2.3 Stada Arzneimittel Head Lice Infestation Treatment Product and Services
2.2.4 Stada Arzneimittel Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Stada Arzneimittel Recent Developments/Updates
2.3 Prestige Brands
2.3.1 Prestige Brands Details
2.3.2 Prestige Brands Major Business
2.3.3 Prestige Brands Head Lice Infestation Treatment Product and Services
2.3.4 Prestige Brands Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Prestige Brands Recent Developments/Updates
2.4 Oystershell Consumer Health
2.4.1 Oystershell Consumer Health Details
2.4.2 Oystershell Consumer Health Major Business
2.4.3 Oystershell Consumer Health Head Lice Infestation Treatment Product and Services
2.4.4 Oystershell Consumer Health Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Oystershell Consumer Health Recent Developments/Updates
2.5 Reckitt Benckier
2.5.1 Reckitt Benckier Details
2.5.2 Reckitt Benckier Major Business
2.5.3 Reckitt Benckier Head Lice Infestation Treatment Product and Services
2.5.4 Reckitt Benckier Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Reckitt Benckier Recent Developments/Updates
2.6 Perrigo
2.6.1 Perrigo Details
2.6.2 Perrigo Major Business
2.6.3 Perrigo Head Lice Infestation Treatment Product and Services
2.6.4 Perrigo Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Perrigo Recent Developments/Updates
2.7 ParaPRO
2.7.1 ParaPRO Details
2.7.2 ParaPRO Major Business
2.7.3 ParaPRO Head Lice Infestation Treatment Product and Services
2.7.4 ParaPRO Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 ParaPRO Recent Developments/Updates
2.8 TecLabs
2.8.1 TecLabs Details
2.8.2 TecLabs Major Business
2.8.3 TecLabs Head Lice Infestation Treatment Product and Services
2.8.4 TecLabs Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 TecLabs Recent Developments/Updates
2.9 Alliance Pharma Inc.
2.9.1 Alliance Pharma Inc. Details
2.9.2 Alliance Pharma Inc. Major Business
2.9.3 Alliance Pharma Inc. Head Lice Infestation Treatment Product and Services
2.9.4 Alliance Pharma Inc. Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Alliance Pharma Inc. Recent Developments/Updates
2.10 Nuvo Pharmaceuticals
2.10.1 Nuvo Pharmaceuticals Details
2.10.2 Nuvo Pharmaceuticals Major Business
2.10.3 Nuvo Pharmaceuticals Head Lice Infestation Treatment Product and Services
2.10.4 Nuvo Pharmaceuticals Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Nuvo Pharmaceuticals Recent Developments/Updates
2.11 Medexus Pharmaceuticals
2.11.1 Medexus Pharmaceuticals Details
2.11.2 Medexus Pharmaceuticals Major Business
2.11.3 Medexus Pharmaceuticals Head Lice Infestation Treatment Product and Services
2.11.4 Medexus Pharmaceuticals Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Medexus Pharmaceuticals Recent Developments/Updates
2.12 Logic Product Group
2.12.1 Logic Product Group Details
2.12.2 Logic Product Group Major Business
2.12.3 Logic Product Group Head Lice Infestation Treatment Product and Services
2.12.4 Logic Product Group Head Lice Infestation Treatment Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Logic Product Group Recent Developments/Updates
3 Competitive Environment: Head Lice Infestation Treatment by Manufacturer
3.1 Global Head Lice Infestation Treatment Sales Quantity by Manufacturer (2020-2025)
3.2 Global Head Lice Infestation Treatment Revenue by Manufacturer (2020-2025)
3.3 Global Head Lice Infestation Treatment Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Head Lice Infestation Treatment by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Head Lice Infestation Treatment Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Head Lice Infestation Treatment Manufacturer 麻豆原创 Share in 2024
3.5 Head Lice Infestation Treatment 麻豆原创: Overall Company Footprint Analysis
3.5.1 Head Lice Infestation Treatment 麻豆原创: Region Footprint
3.5.2 Head Lice Infestation Treatment 麻豆原创: Company Product Type Footprint
3.5.3 Head Lice Infestation Treatment 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Head Lice Infestation Treatment 麻豆原创 Size by Region
4.1.1 Global Head Lice Infestation Treatment Sales Quantity by Region (2020-2031)
4.1.2 Global Head Lice Infestation Treatment Consumption Value by Region (2020-2031)
4.1.3 Global Head Lice Infestation Treatment Average Price by Region (2020-2031)
4.2 North America Head Lice Infestation Treatment Consumption Value (2020-2031)
4.3 Europe Head Lice Infestation Treatment Consumption Value (2020-2031)
4.4 Asia-Pacific Head Lice Infestation Treatment Consumption Value (2020-2031)
4.5 South America Head Lice Infestation Treatment Consumption Value (2020-2031)
4.6 Middle East & Africa Head Lice Infestation Treatment Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Head Lice Infestation Treatment Sales Quantity by Type (2020-2031)
5.2 Global Head Lice Infestation Treatment Consumption Value by Type (2020-2031)
5.3 Global Head Lice Infestation Treatment Average Price by Type (2020-2031)
6 麻豆原创 Segment by End User
6.1 Global Head Lice Infestation Treatment Sales Quantity by End User (2020-2031)
6.2 Global Head Lice Infestation Treatment Consumption Value by End User (2020-2031)
6.3 Global Head Lice Infestation Treatment Average Price by End User (2020-2031)
7 North America
7.1 North America Head Lice Infestation Treatment Sales Quantity by Type (2020-2031)
7.2 North America Head Lice Infestation Treatment Sales Quantity by End User (2020-2031)
7.3 North America Head Lice Infestation Treatment 麻豆原创 Size by Country
7.3.1 North America Head Lice Infestation Treatment Sales Quantity by Country (2020-2031)
7.3.2 North America Head Lice Infestation Treatment Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Head Lice Infestation Treatment Sales Quantity by Type (2020-2031)
8.2 Europe Head Lice Infestation Treatment Sales Quantity by End User (2020-2031)
8.3 Europe Head Lice Infestation Treatment 麻豆原创 Size by Country
8.3.1 Europe Head Lice Infestation Treatment Sales Quantity by Country (2020-2031)
8.3.2 Europe Head Lice Infestation Treatment Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Head Lice Infestation Treatment Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Head Lice Infestation Treatment Sales Quantity by End User (2020-2031)
9.3 Asia-Pacific Head Lice Infestation Treatment 麻豆原创 Size by Region
9.3.1 Asia-Pacific Head Lice Infestation Treatment Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Head Lice Infestation Treatment Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Head Lice Infestation Treatment Sales Quantity by Type (2020-2031)
10.2 South America Head Lice Infestation Treatment Sales Quantity by End User (2020-2031)
10.3 South America Head Lice Infestation Treatment 麻豆原创 Size by Country
10.3.1 South America Head Lice Infestation Treatment Sales Quantity by Country (2020-2031)
10.3.2 South America Head Lice Infestation Treatment Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Head Lice Infestation Treatment Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Head Lice Infestation Treatment Sales Quantity by End User (2020-2031)
11.3 Middle East & Africa Head Lice Infestation Treatment 麻豆原创 Size by Country
11.3.1 Middle East & Africa Head Lice Infestation Treatment Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Head Lice Infestation Treatment Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Head Lice Infestation Treatment 麻豆原创 Drivers
12.2 Head Lice Infestation Treatment 麻豆原创 Restraints
12.3 Head Lice Infestation Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Head Lice Infestation Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Head Lice Infestation Treatment
13.3 Head Lice Infestation Treatment Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Head Lice Infestation Treatment Typical Distributors
14.3 Head Lice Infestation Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Arbor Pharmaceuticals
Stada Arzneimittel
Prestige Brands
Oystershell Consumer Health
Reckitt Benckier
Perrigo
ParaPRO
TecLabs
Alliance Pharma Inc.
Nuvo Pharmaceuticals
Medexus Pharmaceuticals
Logic Product Group
听
听
*If Applicable.
